January 30, 2022 Journal article Open Access

Ahan Gadkari; Sofia Dash

JSON-LD (schema.org) Export

{
  "inLanguage": {
    "alternateName": "eng", 
    "@type": "Language", 
    "name": "English"
  }, 
  "about": [
    {
      "@id": "", 
      "@type": "CreativeWork"
    }, 
    {
      "@id": "https://hdl.handle.net/100.1/ijrte.E66750110522", 
      "@type": "CreativeWork"
    }
  ], 
  "description": "<p>The availability of vaccinations against COVID-19 provides hope for containing the epidemic, which has already claimed over 2.84 million lives. However, inoculating millions of individuals worldwide would need large vaccine manufacturing followed by fair distribution. A barrier to vaccine development and dissemination is the developers&#39; intellectual property rights. India and South Africa have jointly sought to the World Trade Organization that certain TRIPS rules of COVID-19 vaccines, medicines, and treatments be waived. This piece argues for such a waiver, highlighting the unique circumstances that exist. It believes that TRIPS&#39;s flexibilities are inadequate to cope with the present epidemic, particularly for nations without pharmaceutical manufacturing competence.</p>", 
  "license": "https://creativecommons.org/licenses/by/4.0/legalcode", 
  "creator": [
    {
      "affiliation": "4th Year BA. LLB Candidate, O.P. Jindal Global  University, Jindal Global Law School, Sonipat, India.", 
      "@type": "Person", 
      "name": "Ahan Gadkari"
    }, 
    {
      "affiliation": "1st Year BA. LLB Candidate, O.P. Jindal Global University,  Jindal Global Law School, Sonipat, India.", 
      "@type": "Person", 
      "name": "Sofia Dash"
    }
  ], 
  "headline": "Not Tripping over TRIPS: An Analysis of  Necessity and Legality of the COVID-19 TRIPS  Waiver Proposal", 
  "image": "https://zenodo.org/static/img/logos/zenodo-gradient-round.svg", 
  "datePublished": "2022-01-30", 
  "keywords": [
    "Intellectual Property Rights, COVID-19 Vaccines, TRIPS Agreement, WTO"
  ], 
  "url": "https://zenodo.org/record/5804101", 
  "contributor": [
    {
      "affiliation": "Publisher", 
      "@type": "Person", 
      "name": "Blue Eyes Intelligence Engineering  and Sciences Publication (BEIESP)"
    }
  ], 
  "@context": "https://schema.org/", 
  "identifier": "https://doi.org/10.35940/ijrte.E6675.011052", 
  "@id": "https://doi.org/10.35940/ijrte.E6675.011052", 
  "@type": "ScholarlyArticle", 
  "name": "Not Tripping over TRIPS: An Analysis of  Necessity and Legality of the COVID-19 TRIPS  Waiver Proposal"
}